fig2

Figure 2. Overview of responses to the questionnaire on FH screening, diagnosis, treatment, and guideline awareness among pediatricians in Shizuoka Prefecture. Panels A-G illustrate the distribution of answers to specific survey items. (A) Is school-age screening for FH conducted in your medical service region? (n = 47); (B) Do you have experience in the diagnosis and treatment of pediatric familial hypercholesterolemia? (n = 47); (C) Do you have experience with statin therapy in school-aged children with familial hypercholesterolemia? (n = 47); (D) Are you currently managing any patients with familial hypercholesterolemia? (n = 47); (E) Did you know that genetic testing for familial hypercholesterolemia has been covered by insurance in Japan since April 2022? (n = 47); (F) Do you know the 2022 Pediatric Familial Hypercholesterolemia Management Guidelines? (n = 46); (G) Do you follow the 2022 Pediatric Familial Hypercholesterolemia Management Guidelines in the treatment of familial hypercholesterolemia? (n = 43). FH: Familial hypercholesterolemia.